http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006036054-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6dc05c47e3860f18d75492b4647411c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f2a0495173c2ec76880b9253827e735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e9204a8b5de63c9523aacda0fc699d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a284d0e4f0aed22b60887c1adb50e5bc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| filingDate | 2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39e80a3713935f096afc832dea491a8c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ea0c7ff8525592b142bf473e1b68b95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2899501c00993b9b93c24100800a90e |
| publicationDate | 2006-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2006036054-A1 |
| titleOfInvention | Treatment of prevention of unscheduled bleeding in women on progestogen containing medication |
| abstract | The present invention relates to a method of treating or preventing unscheduled bleeding in women, said unscheduled bleeding being the result of repeated administration of a hormonal composition that contains a progestogen, wherein the method comprises the administration of an effective amount of Renin Angiotensin System (RAS) suppressor selected from the group consisting of angiotensin converting enzyme inhibitors; angiotensin II receptor antagonists; renin inhibitors and combinations thereof. Other aspects of the invention relate to a pharmaceutical composition containing a RAS suppressor and a progestogen and to a pharrnaceutical kit comprising a plurality of dosage units, wherein at least one dosage unit contains a progestogen; at least one dosage unit contains an estrogen; and at least one dosage unit contains a RAS suppressor. |
| priorityDate | 2004-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 483.